Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priti Hegde

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|October 14, 2022
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical ResectionSara Lonardi, Halla Nimeiri, Chang Xu, et al.
Journal of Translational Medicine|March 26, 2013
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myelomaCongfen Li, Chikara Takahashi, Liangxuan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
The Oncologist|March 10, 2017
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal CancerRocío García-Carbonero, Eric van Cutsem, Fernando Rivera, et al.
Nature Communications|June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor typesRomain Banchereau, Ning Leng, Oliver Zill, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Frontiers in Neurology|November 16, 2020
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain TumorsLori A Ramkissoon, Worthy Pegram, James Haberberger, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|October 14, 2022
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical ResectionSara Lonardi, Halla Nimeiri, Chang Xu, et al.
Journal of Translational Medicine|March 26, 2013
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myelomaCongfen Li, Chikara Takahashi, Liangxuan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
The Oncologist|March 10, 2017
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal CancerRocío García-Carbonero, Eric van Cutsem, Fernando Rivera, et al.
Nature Communications|June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor typesRomain Banchereau, Ning Leng, Oliver Zill, et al.
Diabetes|November 21, 2007
Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese menUlf Risérus, Dennis Sprecher, Tony Johnson, et al.
Transplantation and Cellular Therapy|February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory HurdlesKedar Kirtane, Michael Kalos, Rocky Billups, et al.
Frontiers in Neurology|November 16, 2020
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain TumorsLori A Ramkissoon, Worthy Pegram, James Haberberger, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Pageof 3